A carregar...
Withdrawal or continuation of cholinesterase inhibitors or memantine or both, in people with dementia
BACKGROUND: Dementia is a progressive syndrome characterised by deterioration in memory, thinking and behaviour, and by impaired ability to perform daily activities. Two classes of drug ‐ cholinesterase inhibitors (donepezil, galantamine and rivastigmine) and memantine ‐ are widely licensed for deme...
Na minha lista:
| Publicado no: | Cochrane Database Syst Rev |
|---|---|
| Main Authors: | , , , , , , |
| Formato: | Artigo |
| Idioma: | Inglês |
| Publicado em: |
John Wiley & Sons, Ltd
2021
|
| Acesso em linha: | https://ncbi.nlm.nih.gov/pmc/articles/PMC8094886/ https://ncbi.nlm.nih.gov/pubmed/35608903 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1002/14651858.CD009081.pub2 |
| Tags: |
Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!
|